Downregulation of Circ-CEP128 Enhances the Paclitaxel Sensitivity of Cervical Cancer Through Regulating miR-432-5p/MCL1
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine,Ecology, Evolution, Behavior and Systematics,Biochemistry
Link
https://link.springer.com/content/pdf/10.1007/s10528-022-10201-y.pdf
Reference36 articles.
1. Baettig F, Vlajnic T, Vetter M, Glatz K, Hench J, Frank S, Bihl M, Lopez R, Dobbie M, Heinzelmann-Schwarz V, Montavon C (2019) Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response. J Immunother Cancer 7:281. https://doi.org/10.1186/s40425-019-0742-6
2. Chen B, Huang S (2018) Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett 418:41–50. https://doi.org/10.1016/j.canlet.2018.01.011
3. Chen LL, Yang L (2015) Regulation of circRNA biogenesis. RNA Biol 12:381–388. https://doi.org/10.1080/15476286.2015.1020271
4. Chen M, Ai G, Zhou J, Mao W, Li H, Guo J (2019) circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893. Biomed Pharmacother 117:109064. https://doi.org/10.1016/j.biopha.2019.109064
5. Craig RW (2002) MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16:444–454. https://doi.org/10.1038/sj.leu.2402416
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Roles of CircRNA-miRNA Networks in Cancer Development and Therapeutic Response;Non-coding RNA Research;2024-09
2. Promising predictive molecular biomarkers for cervical cancer (Review);International Journal of Molecular Medicine;2024-04-04
3. LncRNA BCRT1 depletion suppresses cervical cancer cell growth via sponging miR-432-5p/CCR7 axis;3 Biotech;2023-12-19
4. Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance;Frontiers in Pharmacology;2023-06-08
5. Study on the intake and efficacy of nab-paclitaxel in patients with advanced cervical cancer;European Journal of Gynaecological Oncology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3